These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

339 related articles for article (PubMed ID: 28478600)

  • 1. Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections.
    Nelson AN; Justo JA; Bookstaver PB; Kohn J; Albrecht H; Al-Hasan MN
    Infection; 2017 Oct; 45(5):613-620. PubMed ID: 28478600
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis.
    Battle SE; Bookstaver PB; Justo JA; Kohn J; Albrecht H; Al-Hasan MN
    J Antimicrob Chemother; 2017 Jan; 72(1):299-304. PubMed ID: 27986899
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infections.
    Kutob LF; Justo JA; Bookstaver PB; Kohn J; Albrecht H; Al-Hasan MN
    Int J Antimicrob Agents; 2016 Nov; 48(5):498-503. PubMed ID: 27590704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combination therapy vs. monotherapy for Gram-negative bloodstream infection: matching by predicted prognosis.
    Justo JA; Bookstaver PB; Kohn J; Albrecht H; Al-Hasan MN
    Int J Antimicrob Agents; 2018 Mar; 51(3):488-492. PubMed ID: 28919195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stratification of the impact of inappropriate empirical antimicrobial therapy for Gram-negative bloodstream infections by predicted prognosis.
    Cain SE; Kohn J; Bookstaver PB; Albrecht H; Al-Hasan MN
    Antimicrob Agents Chemother; 2015 Jan; 59(1):245-50. PubMed ID: 25348527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of fluoroquinolone resistance in Gram-negative bloodstream infections on healthcare utilization.
    Brigmon MM; Bookstaver PB; Kohn J; Albrecht H; Al-Hasan MN
    Clin Microbiol Infect; 2015 Sep; 21(9):843-9. PubMed ID: 26003282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Empirical fluoroquinolones versus broad-spectrum beta-lactams for Gram-negative bloodstream infections in the absence of antimicrobial resistance risk factors.
    Al-Hasan MN; Gould AP; Drennan C; Hill O; Justo JA; Kohn J; Bookstaver PB
    J Glob Antimicrob Resist; 2020 Sep; 22():87-93. PubMed ID: 31887412
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections.
    Dan S; Shah A; Justo JA; Bookstaver PB; Kohn J; Albrecht H; Al-Hasan MN
    Antimicrob Agents Chemother; 2016 Apr; 60(4):2265-72. PubMed ID: 26833166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of Early De-escalation of Antimicrobial Therapy on Risk of Clostridioides difficile Infection Following Enterobacteriaceae Bloodstream Infections.
    Seddon MM; Bookstaver PB; Justo JA; Kohn J; Rac H; Haggard E; Mediwala KN; Dash S; Al-Hasan MN
    Clin Infect Dis; 2019 Jul; 69(3):414-420. PubMed ID: 30312362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Derivation of a quick Pitt bacteremia score to predict mortality in patients with Gram-negative bloodstream infection.
    Battle SE; Augustine MR; Watson CM; Bookstaver PB; Kohn J; Owens WB; Baddour LM; Al-Hasan MN
    Infection; 2019 Aug; 47(4):571-578. PubMed ID: 30737765
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short- versus long-course therapy in gram-negative bacilli bloodstream infections.
    Sousa A; Pérez-Rodríguez MT; Suárez M; Val N; Martínez-Lamas L; Nodar A; Longueira R; Crespo M
    Eur J Clin Microbiol Infect Dis; 2019 May; 38(5):851-857. PubMed ID: 30680566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of Penicillin Allergy on Empirical Carbapenem Use in Gram-Negative Bloodstream Infections: An Antimicrobial Stewardship Opportunity.
    Al-Hasan MN; Acker EC; Kohn JE; Bookstaver PB; Justo JA
    Pharmacotherapy; 2018 Jan; 38(1):42-50. PubMed ID: 29105102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of early clinical failure criteria for gram-negative bloodstream infections.
    Rac H; Gould AP; Bookstaver PB; Justo JA; Kohn J; Al-Hasan MN
    Clin Microbiol Infect; 2020 Jan; 26(1):73-77. PubMed ID: 31158519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highly versus less bioavailable oral antibiotics in the treatment of gram-negative bloodstream infections: a propensity-matched cohort analysis.
    Mponponsuo K; Brown KA; Fridman DJ; Johnstone J; Langford BJ; Lee SM; MacFadden DR; Patel SN; Schwartz KL; Daneman N
    Clin Microbiol Infect; 2023 Apr; 29(4):490-497. PubMed ID: 36216237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up blood cultures are associated with improved outcome of patients with gram-negative bloodstream infections: retrospective observational cohort study.
    Giannella M; Pascale R; Pancaldi L; Monari C; Ianniruberto S; Malosso P; Bussini L; Bartoletti M; Tedeschi S; Ambretti S; Lewis R; Viale P
    Clin Microbiol Infect; 2020 Jul; 26(7):897-903. PubMed ID: 32006697
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delays in appropriate antibiotic therapy for gram-negative bloodstream infections: a multicenter, community hospital study.
    Moehring RW; Sloane R; Chen LF; Smathers EC; Schmader KE; Fowler VG; Weber DJ; Sexton DJ; Anderson DJ
    PLoS One; 2013; 8(10):e76225. PubMed ID: 24098449
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Short versus prolonged courses of antibiotic therapy for children with uncomplicated Gram-negative bacteraemia.
    Park SH; Milstone AM; Diener-West M; Nussenblatt V; Cosgrove SE; Tamma PD
    J Antimicrob Chemother; 2014 Mar; 69(3):779-85. PubMed ID: 24159153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravenous Fosfomycin as Adjunctive Therapy for Gram-Negative Bacteria Bloodstream Infections: A Propensity Score Adjusted Retrospective Cohort Study.
    Belati A; Diella L; Bavaro DF; De Santis L; Cotugno S; De Gennaro N; Brindicci G; Maggiore ME; Indraccolo F; Di Gennaro F; Ronga L; Mosca A; Stufano M; Dalfino L; Grasso S; Saracino A
    Int J Antimicrob Agents; 2024 Aug; 64(2):107247. PubMed ID: 38906485
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gram-negative bloodstream infections in hemodialysis patients: A retrospective study
.
    Shimon O; Green H; Eliakim-Raz N; Rozen-Zvi B; Ben-Zvi H; Zohar I; Bishara J; Yahav D
    Clin Nephrol; 2018 Aug; 90(2):117-124. PubMed ID: 29648529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.